UMediC Group Berhad Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for UMediC Group Berhad stock have an average target of RM 0.32, which predicts a 6.67% increase from the current stock price of 0.3.

Price Target: RM 0.32 (+6.67%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	RM 0.32	RM 0.32	RM 0.32	RM 0.32
Change	+6.67%	+6.67%	+6.67%	+6.67%

Analyst Ratings

The average analyst rating for UMediC Group Berhad stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '25	Jul '25	Sep '25	Dec '25	Mar '26	Jun '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

57.30M

from 48.56M

17.99%

from 48.56M

Revenue Next Year

60.95M

from 57.30M

6.37%

from 57.30M

EPS This Year

0.02

from 0.02

-5.96%

from 0.02

EPS Next Year

0.02

from 0.02

9.76%

from 0.02

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jul 31, 2021	Jul 31, 2022	Jul 31, 2023	Jul 31, 2024	Jul 31, 2025	Jul 31, 2026
Revenue	34.12M	50.74M	45.43M	54.57M	48.56M	57.30M
Revenue Growth	44.10%	48.72%	-10.46%	20.11%	-11.01%	17.99%
Gross Profit	12.56M	18.66M	18.93M	22.67M	22.36M	22.23M
Gross Margin	36.82%	36.78%	41.67%	41.55%	46.05%	38.80%
Operating Income	6.68M	8.65M	11.30M	11.22M	9.47M	9.70M
Net Income	5.09M	6.43M	10.32M	8.99M	8.13M	7.75M
EPS	-	-	-	-	0.02	0.02
EPS Growth	-	-	-	-	-9.17%	-5.96%
Forward PE	-	18.99	21.63	20.42	16.26	14.63
Free Cash Flow	-11.22M	6.10M	-6.33M	-4.79M	804.76K	-3.30M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.

Revenue Forecast

Revenue	2026	2027	2028
High	59.9M
Avg	57.3M
Low	54.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	23.3%
Avg	18.0%
Low	12.6%

EPS Forecast

EPS	2026	2027	2028
High	0.02
Avg	0.02
Low	0.02

EPS Growth

EPS Growth	2026	2027	2028
High	-3.7%
Avg	-6.0%
Low	-8.3%